pharmacopeia
GET
/api/v1/drug/sodium-phosphate

Mechanism of action

Sourced from openFDA

Mechanism-of-action classes: Electrolyte Activity; Osmotic Activity.

Indications

Sourced from openFDA
  • Uses For the temporary relief of symptoms associated with mild indigestion. Directions Tip bottle slightly allowing for tablets to fall into the cap.

Dosage & administration

Sourced from openFDA

Directions Tip bottle slightly allowing for tablets to fall into the cap. Use cap to drop tablets into mouth and allow them to dissolve under the tongue. Adults and adolescents (12 years and older) Take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. Children (under 12 years) Take under the direction of your healthcare practitioner.

Warnings & precautions

Sourced from openFDA

Do not use if you ever had an allergic reaction to this product or any of its ingredients. Stop use and ask a doctor if symptoms persist or worsen. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away

Overdosage

Sourced from openFDA

In case of overdose, get medical help or contact a Poison Control Center right away.

Approval history

Sourced from openFDA
  • Mar 3, 1965NDANDA014602Organon
  • Feb 19, 1982NDANDA018508Baxter Hlthcare
  • May 10, 1983NDANDA018892Hospira
  • May 8, 1986NDANDA019513Otsuka Icu Medcl
  • May 28, 1986NDANDA019157Pai Holdings
  • Sep 29, 1989NDANDA019696B Braun
  • Sep 27, 1996NDANDA020577Lukare Medical Llc
  • Jun 1, 2006NDANDA021959Advanz Pharma

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
17,735 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Off Label Use1,3797.8%
  2. 2Nausea1,1146.3%
  3. 3Pyrexia9785.5%
  4. 4Fatigue9065.1%
  5. 5Diarrhoea8855.0%
  6. 6Vomiting8744.9%
  7. 7Drug Ineffective8474.8%
  8. 8Dyspnoea7794.4%
  9. 9Pneumonia6993.9%
  10. 10Anaemia6903.9%
  11. 11Pain6853.9%
  12. 12Headache5813.3%
  13. 13Rash5573.1%
  14. 14Constipation5463.1%
  15. 15Condition Aggravated5333.0%

Literature

View JSON

Recent PubMed references pinned to Sodium Phosphate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 683 ClinicalTrials.gov registrations naming Sodium Phosphate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Sodium Phosphate work?
Mechanism-of-action classes: Electrolyte Activity; Osmotic Activity.
What is Sodium Phosphate used for?
According to FDA labeling, Sodium Phosphate carries indications including: Uses For the temporary relief of symptoms associated with mild indigestion. Directions Tip bottle slightly allowing for tablets to fall into the cap.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Sodium Phosphate?
Sodium Phosphate is classified as Drugs for treatment of hypercalcemia, Electrolyte solutions, Enemas, Osmotically acting laxatives, Electrolyte Activity, Osmotic Activity, Cellular Activity Alteration, Increased Large Intestinal Motility.
What are the brand names for Sodium Phosphate?
Sodium Phosphate is marketed under brand names including Aminosyn 8.5 % with Electrolytes, Sulfite-Free, OsmoPrep, Tis-U-Sol.
Note. Data for sodium-phosphate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients